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CLONAL NATURE OF THE IMMUNE RESPONSE TO
PHOSPHORYLCHOLINE (PC)
V. Cross-Idiotypic Specificity Among Heavy Chains of Murine Anti-PC
Antibodies and PC-Binding Myeloma Proteins*
By J . LATHAM CLAFLIN AND JOSEPH M. DAVIE
(From the Departments of Pathology and Microbiology, Washington University School of Medicine,
St . Louis, Missouri 63110)
Williams et al . (1) in a study of monoclonal IgM cold agglutinins noted that
antisera to different cold agglutinins possessed specificity not only for antigenic
determinants unique to the individual proteins but also for determinants that
were shared by cold agglutinins from a number of individuals . This phenomenon
of shared or cross-idiotypy among immunoglobulins with similar specificity also
has been demonstrated for human proteins with anti-7-globulin activity (2) and
among rabbit (3, 4) and mouse (5) antibodies to streptococcal group carbohy-
drates . In most instances the proteins exhibiting cross-idiotypic reactions had
similar, but not necessarily identical, combining sites, and the idiotypic determi-
nant shared by them was associated with the combining site (2, 5-8) . Support for
the structural similarity of antibodies with similar specificity and shared
idiotypy has been provided by recent findings showing that IgM cold agglutinins,
anti-y-globulins (9, 11), or rabbit antibodies to streptococcal group C carbohy-
drate (7) have strikingly similar heavy and/or light chains .
Previous studies from our laboratory have demonstrated a remarkable similar-
ity in the combining sites of mouse antibodies to phosphorylcholine (PC)'
regardless of the genetic background of the mice . The antibodies from the mouse
strains tested possessed indistinguishable binding specificities for a number of
choline analogues (12) and had identical binding-site antigenic determinants
(13) . This suggests a striking conservation of the binding site region of mouse
anti-PC antibodies, even though differences have been shown to exist in other
portions of the variable region (14-16) . In contrast, it was shown (17) that three
PC-binding myeloma proteins that differed in combining specificity (18), as well
as in idiotypes (19) and in light chains (17), have heavy chain sequences which
are virtually identical through the first hypervariable region . These findings
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imply that a prerequisite for all PC-combining activity in mice is a particular
heavy chain subtype. The present study was carried out to test this hypothesis
among PC-binding myeloma proteins and anti-PC antibodies isolated from a
number of different mouse strains. Using a cross-idiotypic assay we found that
each of six different PC-binding myelomaproteins and mouse anti-PC antibodies
of different inbred strains possessed a common antigenic determinant which
could be located primarily in the variable region of the heavy chain. Thus, VH
regions which are independent of the specific binding site have been conserved in
mice.
Materials and Methods
Haptens andHapten-protein Conjugates.
￿
Phosphorylcholine (PC), L-a-glycerophosphorylcholine
(GPC), and choline (C) were obtained from Sigma Chemical Co., St. Louis, Mo. Calcium and
cadmium ions in PC and GPC, respectively, were precipitated with phosphate before use. Chicken
gamma globulin (CGG) and bovine serum albumin (BSA) were conjugated to PC as previously
described (15) .
Plasmacytomas. The plasmacytomas HOPC 8, TEPC 15, McPC 603, MOPC 511, MOPC 460,
MOPC 384, MOPC 21 were obtained from Dr. M. Potter, National Cancer Institute, NIH, Bethesda,
Md. The tumors were maintained by serial transfers in BALB/c mice.
Animals and Immunization.
￿
BALB/c, C58, C57BL/6, DBA/2, A, AKR, and CE mice (6-8 wk of
age) were obtained from Jackson Laboratories, Bar Harbor, Maine. They were immunized
intravenously on days 0 and14 as previously described (15) with 108 pneumococci (R36A) . Sera pooled
from 10 mice per strain were collected 4, 6, and 8 days after the second injection.
Myeloma Proteins and Anti-PC Antibodies . Myeloma proteins and mouse IgM antibodies
specific for PC were isolated by affinity chromatography from a PC-Sepharose immunoadsorbent(20)
as previously described (13). CBPC 2, kindly provided by Doctors M. Potter and S. Rudikoff, NCI, is
a myeloma induced in BALB/c - C57BL/ka (IgC ) CB20 mice which produce a PC-binding IgA (I()
protein with the same binding specificity, amino-terminal heavy and light chain sequences, and
binding site idiotypes as T15 andHS (21) . It carries, however, the heavy chain allotypic determinants
of C57BL/ka (21). Another PC-binding myeloma protein, ALPO 43, provided by Dr. Potter originated
in a congenic strain of BALB/c, BALB/c - AL/N IgC , which carries the IgC H complexlocus of AL/N
mice (22). ALPC 43, which will be described in a later publication, belongs to the IgG3 class and
carries neither the nonbinding site, T15 (16), nor the binding site, H88 (13), idiotypic determinant.
M384 and M21 were purified by isoelectric focusing in an LKB 8100 liquid electrofocusing column
using pH 5-8 Ampholines (LKB Instruments, Inc., Minneapolis, Minn.) . M460, a dinitrophenyl-bind-
ing IgA protein, was a gift from Dr. R. Lynch of our department. The galactan-binding IgA (K)
myeloma proteins, J539 and X44, secreted by plasmacytomas J539 and xRPC 44 (23), respectively,
were gifts from Dr. S. Rudikoff. Normal mouse globulin (NMG) containing IgM, IgA, and IgG was
separated from pooled normal BALB/c serum by elution from DEAE-cellulose.
Affinity Labeling. Purified H8 was affinity-labeled with PC as described by Chesebro and
Metzger (20) . Monomer H8 at 10 -5 M in 0.2 M borate, 0.15 M NaCl, pH 8.2, was reacted with
p-diazonium phenylphosphorylcholine at a final exposure ratio of 4 moles reagent per mole of
combining site. Apaired experiment included 10-8 M PC as asite protector. As shown previously (24)
the binding sites of site-labeled H8 were greater than 90% saturated with covalently bound PC,
whereas site-unlabeled H8 reacted normally with PC.
Immunoglobulin Fractionation. Heavy and light chains of myeloma proteins and anti-PC
antibodies were isolated after partial reduction andalkylation by chromatography on Sephadex G100
columns equilibrated with 1 M propionic acid, 4.5 M urea (25) . The ascending and descending
portions of the heavy and light chain peaks, respectively, were used. Based on radioactive markers,
light chain contamination of heavy chains was less than 1%. Pepsin Fab fragments of M167 and T15
were prepared according to the procedure of Rudikoff et al. (26) .
Preparation ofAnti-idiotypic, Antiallotypic and Anti-kappa Antisera.
￿
An. idiotypic antiserum to
H8 protein was prepared in rabbit Cl as follows. 2 wk after the second monthly injection of 2 mg of
HOPC 8 in complete Freund's adjuvant, serum was collected and passed over a SepharoseJ. LATHAM CLAFLIN AND JOSEPH M. DAVIE
immunoadsorbent coupled (27) with normal BALB/c serum containing 9 mg/mlof M460 . As will be
shown, this antiserum, Cl anti-H8, was idiotypically specific for H8 but possessed, in addition,
antibodies specific for other myeloma proteins that bindPC . The preparation of antibodies specific
for binding site-associated antigenic determinants of H8, anti-H8 has been previously described
(24) . Antiallotypic antiserum was prepared by immunization of A/J mice with M460 protein
according to the procedure of Potter and Lieberman (22) . This antiserum reacted only with IgA
myeloma proteins and presumably detected the A'2 . " . " IgC determinants . A rabbit antiserum
specific for mouse kappa chains was purchased from Gateway Immunosera Co ., Cahokia, Ill . The
gammaglobulin fraction foruse in the immunoassay described belowwasseparated from each of these
three antisera by DEAE-cellulose chromatography using 0.05M phosphate buffer (PB), pH 8.0 .
Detection ofIdiotypic, Allotypic, and Isotypic Determinants .
￿
Distribution of idiotypic specifici-
ties amongPC-binding proteins wasexamined by solid-phaseradioimmunoassay (TBA) (28) usinga
modification of the procedure originally described by Kunkel et al . (2) for detecting cross-idiotypic
specificities among monoclonal anti--y-globulins . Briefly, microtest tubes (Beckman Instruments,
Inc., Fullerton, Calif.) were coated with 0.2 ml of a limiting dilution of idiotypic antiserum to HS as
previously described (24) . After rinsing the tubes with 0.15M NaCl, 0.005M PB, pH 7 .2 (PBS), 0.21
ml of ['z5I]M167 (1.9 ng/ml
￿
30,000 cpm/ml) in PBS containing 1% BSA, 0.1% normal rabbit serum
and various concentrations of inhibitors was added . Tubeswere incubated for14-18 hat 37° C, rinsed
with PBS, and the percentage inhibition of specific binding was determined. Alternatively, microtest
tubes were coated with anti-kappa or with antiallotypic antisera to test for inhibition of binding to
isotypic or allotypic determinants on [" 51]M167 . In one instance a control experiment tested
inhibition of binding to anti-1-18. with [' 251]H8 . Specific and nonspecific binding to antibody-coated
tubes was 23%-29% and <0.5%, respectively, of added radioactivity .
Results
Specificity of Idiotypic Antiserum . The idiotypic antiserum to H8, when
tested in the TBA using ["'I]H8 as the ligand, reacted strongly with H8, but
only weakly with other myeloma proteins with related, but distinguishable,
anti-PC activity (17-19) (e .g . M167, M603, and M511) . Expressedquantitatively,
a 1:100 dilution of the idiotypic antiserum maximally bound 30 ng of H8 and 3.6
ng of M167 under the conditions of the TBA. If, however, [1251]M167 instead of
H8 was used as the reference ligand in the assay, all PC-binding myeloma pro-
teins were seen to inhibit bindingto anti-H8-coated tubes equally well (Fig. 1 and
Table I) . This cross-idiotypic determinant was also found on CBPC 2, a
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FIG. 1 . Idiotypic similarity of PC-binding myeloma proteins . Purified myelomaproteins were
tested for their ability to inhibit the bindingof [' 251]M167 to Cl anti-H8 .
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TABLE I
Specificity of Idiotypic Antiserum
* Myeloma proteins were purified except for J504 and Adj PC 22A where ascites fluid was used.
$From Barstad et al. (17) .
§ ISO, concentration of protein which gives 50% inhibition of binding. Mean results of2-3 experiments.
11 Number designates type of binding specificity pattern for choline analogues (15, 18, 21) .
PC-binding myeloma of C57BL/ka background (21), and on ALPC 43, an IgG3
protein arising in a BALB/c - AL/N 19C H mouse. Each of the PC-binding
myeloma proteins gave comparable inhibition of binding of [1251]M167 to
antibody-coated tubes indicating that serologically the cross-idiotypic determi-
nant on each of these myeloma proteins was identical. Furthermore, pepsin Fab
fragments from both T15 and M167 inhibited binding of [1251]M167 to the
idiotypic antiserum almost as efficiently as the unfragmented proteins (Table 1) .
Control proteins such as normal mouse globulin and other, non-PC-binding
myeloma proteins, including those in the same V,, subgroup as the PC-binding
proteins, showed negligible reaction with the idiotypic antiserum. Thus, this
antigenic determinant, designated V,,-PC, was found on all myelomas which
bound PC, regardless of specificity, and appeared to be associated with variable
region portions of the molecules rather than constant region or allotypic
determinants .
Presence of the Cross-idiotypic Determinant in the Variable Region .
￿
Though
present in T15 and M167 Fab fragments, the cross-idiotypic determinant
appeared not to be located in the binding site, since the monovalent ligand, PC,
failed to inhibit the binding of [1251]M167 in the TBA (Fig. 2 left). This was
corroborated by experiments which demonstrated that anti-VII-PC could react
with H8 in which the combining sites had been blocked by covalently bound PC
groups. As shown in Fig. 2 (right) affinity labeled H8 gave no less inhibition of
Myeloma*
protein
Binding
specificity
Ig
class
VH
subgroup$
ISO§
ng/ml
T15 PC III IgA(K) VHU1 21
T15 Fab 57
HS PC 1 IgA(K) VH1H 18
M603 PC 2 IgA(K) VHU1 24
M511 PC 3 IgA(K) VHI11 19
M167 PC 4 IgA(K) VH111 31
M167 Fab 121
CBPC 2 PC 1 IgA(K) VH11i 27
ALPC 43 PC 5 IgG3 ? 42
M460 DNP IgA(K) VHI > 10,000
M384 LPS IgA(K) > 10,000
J504 ? IgA ? > 10,000
Adj PC 22A ? IgA ? > 10,000
M104 1,3 dextran IgM(X) VHii > 10,000
M173 ? IgG2a(K) VHU1 >10,000
M21 ? IgG,(K) VHU1 >10,000
J539 1,6 galactan IgA(K) VH1i1 >10,000
x44 1,6 galactan IgA(K) VHU1 >10,000O
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FIG . 2. Association of V-PC idiotype with the binding region . Left: PC, PC,6BSA, and
PCZ,CGG were tested forthe ability to inhibitthe reactionsbetween [1211IM167 andC1 anti-H8
(anti-V .-PC), anti-kappa andantiallotype . Right: Site-labeled and unlabeled T15were tested
for their ability to inhibit the binding of [' 26IJM167 to Cl anti-HS (antiV-PC) or [ 11111-18 to
anti-HS. .
binding of [" 5I]M167 to anti-V H-PC than did unlabeled H8 . By contrast,
affinity labeled H8 was a poor inhibitor of the binding of ['25I]H8 to antibodies
(anti-118.) specific for combining site antigenic determinants (24) . However, PC
conjugated to BSA or CGG did inhibit the ['z5I]M167 anti-H8 reaction by 30 and
55%, respectively . Neither of these conjugates influenced the binding of
["5I]M167 to anti-kappa or to antiallotypic sera . These data suggest that the
determinant, though not directly in the PC-binding region, is nevertheless
associated with the site so that steric blockage by the BSA or CGG carrier
proteins occurred .
Chain Association of the Cross-idiotypic Determinant. To test for the
possibility that the common idiotypic determinant described here was situated
on the heavy chain, as the sequence data of Barstad et al . (17) might indicate,
isolated heavy and light chains from four different proteins, H8, M511, M167 and
M603, were tested in the inhibition assay for their ability to bind the idiotypic
antiserum . As shown in Fig . 3, the inhibitory capacity of theH chains from each
of the myeloma proteins (50% inhibition -100 ng/ml) was comparable to that
obtained with the intact proteins (50% inhibition ^-25 ng/ml) . On a molar basis,
Ig was approximately five times more efficient as an inhibitor than H chains .
However, this difference may be due to the bivalent nature of the whole Ig which
should increase its inhibitory capacity . Light chains of these same proteins did
not bind appreciably to the anti-V .-PC idiotypic antibodies . It is unlikely that
whole Ig or L-chain contamination ofH chains could account for the inhibition
observed with heavy chains . Chromatographic analysis showed no peak which
could represent intact, unfractionated protein in the H-chain preparation and, as
described in the Methods, less that 1% of L chains were detected in the H-chain
preparation . More importantly, an idiotypic determinant which depends on an
H-L interaction, the H88 idiotype (24), was not present in the H-chain
preparations of H8 that were used in the experiments described here .
Cross-idiotypic Specificity Among Mouse Anti-DC Antibodies . Purified
mouse IgM anti-PC antibodies were examined forthe presence of the cross-idio-1078
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FIG. 3. Location of V.-PC on the heavy chain. Unfractionated myeloma proteins and heavy
and light chains derived from them were tested for inhibition of binding of ('z5I]M167 to Cl
anti-H8.
typic determinant. As demonstrated in Fig. 4, anti-PC antibodies obtained from
mice representing each of the major IgC,, allotypic subgroups possessed the
cross-idiotypic determinant common to the heavy chain of the PC-binding
myeloma proteins (BALB/c and C58, a'; C57BL/6, a2; DBA/2, a3; A and AKR,
a4; and CE, a5). Moreover, since each antibody preparation gave comparable
inhibition, the antigenic determinant on anti-PC antibodies from each of these
strains was idiotypically identical to that on H8. In addition, this cross-idiotypic
determinant was present on anti-PC antibody isolated from the sera (12, 13) of
three different, immunized wild Mus musculus . It was not found on anti-PC
antibodies of guinea pigs, rats, hamsters, and Peromyscus species. Thus,
evidence is provided that heavy chain variable region portions ofmurine anti-PC
antibodies, in addition to binding site determinants, e.g. H8", are preserved
among different mouse strains.
Discussion
The present studies describe a cross-idiotypic determinant, V,_,-PC, which is
shared by PC-binding myeloma proteins that differ in binding specificity and
have unrelated individual antigenic specificities. These immunoglobulins also
differ in genetic origin, immunoglobulin class, and in the K-light chain subgroup.
Of particular importance is the finding that V,,-PC can be localized to the vari-
able region of the heavy chain. This result supports the conclusions of Barstad
and Rudikoff (17) that BALB/c PC-binding myeloma proteins and, by inference,
antibodies to PC, have structurally similar heavy chain variable region(s).
Indeed, as shown by the present study, induced IgM anti-PC antibodies isolated
from genetically unrelated strains of mice possess the V,,-PC determinant.
There now exists three knownvariable region markers formurine immunoglob-
ulins with specificity for PC (Table II). The first, T15, is a nonbinding site
determinant which requires both heavy and light chains for full expression of itsc7
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FIG. 4. Similarity of V-PC cross-idiotypic determinant among mouse anti-PC antibodies.
Purified anti-PC antibodies inhibited the reaction between ["5I]M167 and Cl anti-H8.
TABLE 11
Variable Region Antigenic Determinants on PC-Binding Immuno-
globulins
* T15determinant, ref. 15 and 16; H8, determinant, ref. 13 and 24; V-PC,
this paper.
$ Anti-PC antibody found in mice representing designated allotype (22) .
§Some, but not all, strains positive (16).
11 IgA(K) myeloma proteins induced in BALBJc mice (IgC H a').
antigenicity (14, 16, 24). Except for some possible discrepancies (29; Claflin and
Davie, unpublished observations), this determinant is found principally on
anti-PC antibodies or myelomas raised in mice of the al IgC . heavy chain linkage
group (16) and does not correlate with binding site specificity (15) . The second
Source ofPC-binding
immunoglobulin
T15
Determinant*
HS. V-PC
IgC allotype$
a' + and -§ + +
a2 - + +
a3 - + +
a° - + +
as - + +
Myeloma protein
T15group + + +
M167 - - +
M603 - - +
M511 - - +
0
z
40 - H8
0 BALB/C
z O C58
C57BL/6 V DBA/2
6A d 20 * AKR
O CE1080
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determinant, H8,,, has been shown to lie in the binding site (24) and correlates
precisely with binding specificity (12, 13) . Therefore, antibodies raised in mice
representative of all heavy chain linkage groups and myeloma proteins in the T15
group possess this determinant . The third determinant, V,-PC, as shown in this
paper, lies solely-on the heavy chain and is found on all anti-PC immunoglobu-
lins regardless of their specificity .
The latter determinant, V.-PC, is clearly on a variable region of the heavy
chain although its precise location is not determined . In other instances of
cross-idiotypy, attempts to find activity on isolated H or L chains have been
unsuccessful (4, 8, 9, see 30), and instead, have relied on structural studies to
associate a cross-idiotypic determinant with a particular polypeptide chain (see
10, 31, 32) . Recently, Thunberg and Kindt (4) have successfully employed
heterologous recombinant molecules to localize an idiotypic determinant.
V.-PC also appears loosely associated with the combining site, since PC-
protein conjugates, but not PC, alter the binding of the idiotypic antibody to
V,,-PC . Apparently the V,{-PC determinant is not in the precise region of PC
binding, but is sufficiently close to it so that steric blockage occurs with portions
of the protein conjugate which are adjacent to the PC-linkage . While this
approach has obvious limitations, it can be used along with structural data to
indicate potential locations of V,,-PC . In fact, considerable information concern-
ing the tertiary structure of one of the PC-binding proteins used in the present
study has been generated by X-ray crystallographic studies (33) . In M603,PC is
bound at one end of the Fab in a large cleft, the entire surface of which is
composed of five hypervariable regions . PC, even though it interacts with at least
four of these hypervariable regions, occupies only a small portion of the cleft.
Thus,PC binding leaves most of thesurface of the hypervariable loops"free" . On
the other hand, PC-protein binding would likely cover all heavy chain hypervari-
able regions in the cleft . Of the possible candidates for V.-PC location, the first
hypervariable region of the heavy chain appears the most likely, since it, in
contrast to the second and third (S . Rudikoff, personal communication), is the
only one which is structurally identical in all the PC-binding proteins so far
sequenced and which is not found in the heavy chain of other immunoglobulins
(17) .
The present findings support an ever growing body of literature which
indicates that antibody molecules with similar specificity are similarstructurally
and/or antigenically . Among human IgM proteins with anti- -y-globulin activity
(6, 10, 11) and among rabbit and mouse antistreptococcal carbohydrate
antibodies (4, 5, 7, 31), cross-idiotypic determinants are more strongly associated
with the antibody combining site and/or hypervariable regions than with other
portions of the variable regions . These conclusions are based on a variety of data,
including similarity in specificity for a particular antigen, antigen or hapten
inhibition of binding to idiotype and sequence similarity of hypervariable regions
in immunoglobulins in which the remainder of the variable region is virtually
identical to a number of other idiotypically unrelated proteins . As exemplified by
thePC system, structural studies have shown that a particular VH , heavy chain
subtype is present in three different BALB/c myeloma proteins (17) and in one
protein of C57BL origin (21) . Since the presence of the V,,-PC determinantJ. LATHAM CLAFLIN AND JOSEPH M. DAVIE
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correlated with the occurrence of the PC V,,I I I subtype in these sequenced
proteins, it is probable that the heavy chains ofeach oftheother proteins (MOPC
511 and ALPO 43) belong to this V,~I subtype as well. Indeed, one could predict
that a prerequisite for PC-binding activity in. all mice, regardless of genetic
background, is this PC V.,<< subtype. Additional sequence data will be
required to determine the extent to which this heavy chain has been conserved in
anti-PC antibodies.
Finally, it should be emphasized that all immunoglobulins undoubtedly
possess multiple "idiotypic" determinants. While we have demonstrated three
such determinants on anti-PC immunoglobulins, there are probably others on
the same molecules. The crucial point in terms of using these antigenic
determinants as structural or clonal probes, is that each, because of different
structural localization, may have completely different distributions amongother
immunoglobulins. Thus, distributions of the three idiotypic markers among
anti-PC molecules of mice are dramatically different and could lead to different
conclusions if used as genetic markers without knowledge of their structural
correlates. It should be obvious that most, if not all, idiotypic antisera probably
contain antibodies to several determinants. Therefore, studies which use
idiotypic antisera as genetic or structural probes are most informative if the
number and location ofthe idiotypic determinants measured are known. Without
the structural correlates, the use ofidiotypes mayonly confuseourunderstanding
of antibody interrelationships; with more precise definition of the idiotypic
determinants, they may become our most useful probes.
Summary
Seven mouse myeloma proteins with specificity for phosphorylcholine (PC) were
found to share a common antigenic determinant. This group of proteins
contained members which differed in genetic origin, heavy chain class, K-chain
subgroup, individual antigenic determinants and specificity for choline ana-
logues. The cross-idiotypic determinant, V.-PC, was antigenically similar in
each of the proteins and was associated with the variable portion of the heavy
chain in the region ofthe antibody combining site. Further studies showed that
an indistinguishable determinant was present on IgM anti-PC antibodies
isolated from all strains of mice tested regardless of histocompatibility or heavy
chain allotype. In view of the finding that this cross-idiotypic determinant was
not found on antibodies or myeloma proteins which lacked specificity for PC, the
data strongly suggest that a particular heavy chain variable region has been
preserved in all mouse antibodies with specificity for PC.
Received for publication 23 December 1974.
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